Ascentage Pharma Group International ADR

Ascentage Pharma Group International ADR represents American Depositary Receipts of the biotechnology company Ascentage Pharma Group International. These ADRs serve the primary function of making shares of the company, which is originally based in China, accessible to American investors on U.S. financial markets. Ascentage Pharma focuses on the research, development, and marketing of innovative therapies for oncology, hepatitis B, age-related diseases, and other maladies. The company’s presence in the biotechnology sector is significant due to its expansive pipeline of novel drugs, guided by its proprietary protein-protein interactions disruption technology. By trading as ADRs, Ascentage Pharma ensures greater liquidity and exposure among investors outside its home market, aligning with the global investment community's interest in biopharmaceutical advancements and treatments for complex diseases.